https://doi.org/10.1016/j.redox.2022.102451
K
Kaiqiang Li
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
68
Papers
668
Citations
12
h-index
19
i10-index
Kaiqiang Li is an academic researcher from Fujian Normal University. The author has contributed to research in topics: Nanoplatforms for cancer theranostics & Extracellular vesicles in disease & Phytochemistry and Bioactive Compounds. The author has an h-index of 12, co-authored 58 publications.
ORCID: 0000-0003-4307-0845Papers by this author
worksTRIM7 modulates NCOA4-mediated ferritinophagy and ferroptosis in glioblastoma cells
2022 · Redox Biology · 123 citations
Multi-omics study identifies that PICK1 deficiency causes male infertility by inhibiting vesicle trafficking in Sertoli cells
2023 · Reproductive Biology and Endocrinology · 11 citations
https://doi.org/10.1186/s12958-023-01163-w
CILP2: A prognostic biomarker associated with immune infiltration in colorectal cancer
2023 · Heliyon · 7 citations
https://doi.org/10.1016/j.heliyon.2023.e15535
Polarity protein Par6: Unraveling its mechanisms in tumor development and research advances
2025 · Cellular Signalling · 1 citations
https://doi.org/10.1016/j.cellsig.2025.112181
Integrating single-cell transcriptomics and machine learning reveals 4-aminobiphenyl exposure signatures and novel diagnostic biomarkers in bladder cancer
2025 · Discover Oncology · 0 citations
https://doi.org/10.1007/s12672-025-03819-y
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat